If you suspect that you have skin cancer or have recently been diagnosed and were told you need treatment, schedule an appointment with us today. We offer GentleCure (Image-Guided SRT)—the surgery-free, gold-standard treatment for skin cancer. On your first visit, we will review your pathology report, discuss your treatment goals, and work with you to determine the treatment option that best meets your needs
GentleCure is a gentle, surgery-free treatment that is safe and has a 99%+ cure rate in basal and squamous cell skin cancers. Treatment is done right in the dermatology office over the course of a few weeks using an advanced Image-Guided SRT machine. It is the only skin cancer treatment with ultra-sound imaging that lets you see the cancer on the screen and review the progress made throughout the course of treatment until there are no visible signs of cancer.
GentleCure (Image-Guided SRT) is designed to treat skin cancer without the discomfort and cosmetic issues often associated with surgery. There is no cutting, surgical scarring, or need for reconstructive surgery, and you can maintain your normal daily activities throughout treatment.
At each treatment session, you will sit in a chair and ultrasound gel will be applied to the site of the cancer. Using an imaging wand, we will look at a detailed image of your cancer on screen. You can see the image yourself from the comfort of the chair. We will use that image to measure the size and shape of the tumor, calculate the precise dose of treatment, and define the treatment area.
Once the imaging is complete, the arm of the device will be placed over the treatment site and the exact dose of X-ray energy will be used to treat the cancer site without harming the healthy tissue around it.
Each treatment session takes about 15 minutes from the time you walk in the door to when you leave the office. You will come back several times a week for short treatment sessions, and in 4-to-7 weeks, treatment will be complete.
Patients report being satisfied with GentleCure (Image-Guided SRT). In a survey of more than 12,000 patients who completed treatment, 99.9% reported being happy with their treatment decision and said they would recommend GentleCure (Image-Guided SRT) to others.
Visit GentleCure.com/Patient Stories to hear from some of them.
At Southside Dermatology and Skin Cancer Surgery, our team of dermatologists reviewed the published research and here is what we found:
Yu L, et al. Oncol Ther. 2021;9(1):153-166.
Retrospective chart review evaluating LC rates of 1632 patients with 2917 stage 0-II carcinomas
In 2021, chart reviews were conducted for 1632 patients who had Image-Guided SRT to treat one or more early-stage basal or squamous cell skin cancers. Of those patients, 2917 skin cancers in total were treated. The results showed a 99.3% cure rate with Image-Guided SRT, which we believe to be equal to or better than Mohs surgery.
In 2022 and 2023, additional studies were published that showed the efficacy and safety of Image-Guided SRT to be superior to non-image-guided forms of radiation therapy across skin cancer types—confirming its use as a first-line treatment for basal and squamous cell skin cancers. This means doctors and patients should give equal consideration to Mohs surgery and surgery-free Image-Guided SRT as standards of care.
More information about the published research supporting the use of GentleCure (Image-Guided SRT) can be found here.
There are several different radiation-based treatments available for skin cancer. But the safety, cure rates, and cosmetic outcomes vary based on the treatment technology and clinical protocols used. We chose GentleCure (Image- Guided SRT) because it is the only skin cancer treatment with advanced imaging that lets us see and measure the cancer and adapt the dose to precisely what you need at each stage of treatment. It has also been shown to be the safest and most effective of all radiation-based treatments for skin cancer with superior cosmetic results.
If you are considering radiation therapy to treat your skin cancer, make sure you are getting GentleCure (Image- Guided SRT) with adaptive radiotherapy protocols. It’s the safe, effective, and gentle way to treat skin cancer using the most advance treatment technology available today.
No two cases of skin cancer are the same, so treatment results may vary from patient to patient. But the pictures below are typical of the results seen by patients who have received GentleCure (Image-Guided SRT).
Patient with basal cell skin cancer on the top of the ear before treatment with GentleCure (Image-Guided SRT). You can see the cancer on the skin. The ultrasound image clearly defines the skin cancer under the skin, indicating the full depth, width, and breadth of the cancer.
About half way through treatment with GentleCure (Image-Guided SRT), you can see the cancer reducing in size on the outside of the skin. The ultrasound image shows that the cancer under the skin has also been reduced
At the two-week follow-up visit after treatment was completed, the outside of the ear shows no signs of cancer. The ultrasound image shows that GentleCure (Image-Guided SRT) continued to eliminate the cancer. At the 30-week follow-up appointment, the ultrasound image showed no signs of cancer
With most insurance plans, you may have to pay some out-of-pocket cost. That cost will depend on your specific health plan coverage and co-pay policy. Before you commit to a treatment option, we will work with your insurance plan to determine the potential cost to you, so you can make an informed treatment decision. If you are worried about affording treatment, let us know and we can discuss our financial assistance options.
When X-ray energy is used to kill cancer cells, your body will replace the dead cancer cells with healthy tissue over time. There is no surgical scarring and no need for reconstructive surgery. There is, however, a small risk of skin atrophy (thinning of the skin) and pigment changes (changes in the color of the skin) at the treatment site. Other potential side effects may include skin inflammation with redness and swelling at the treatment site. Topical creams or ointments can be used over the course of treatment to minimize these side effects, and the side effects usually go away 2-to 6-weeks after treatment is complete. There is also a risk of alopecia (hair loss) in the treated area only. In the 7 years that patients have been receiving GentleCure (Image-Guided SRT), there have been NO reported cases of secondary skin cancers occuring as a result of treatment.
Dr. Fischer is experienced in all types of dermatologic procedures. She served as the co-director of the procedural dermatology fellowship, as well as the program director, for the Roger Williams Medical Center in Providence, Rhode Island. She also served as a clinical instructor at the Boston University School of Medicine.
A distinguished student, Dr. Fischer graduated summa cum laude from the University of Tulsa, with a bachelor’s degree in geology and biology. She was first in her class at the University of Oklahoma College of Medicine, graduating with special distinction. Dr. Fischer was named chief resident in her final year of dermatology residency at the University of Oklahoma Health Sciences Center. She went on to complete additional rotations in dermatology and laser skin treatments at Harvard-Massachusetts General Hospital in Boston.
She is board-certified in her specialty by the American Board of Dermatology.
In her free time she enjoys spending time with her two young children, six cats, and one dog, as well as spending time on her family farm.
Robert Fischer, MD, a board-certified dermatologist and dermatologic surgeon at Southside Dermatology, offers the Tulsa, Oklahoma, community his expertise in Mohs surgery, cosmetic reconstruction, and the diagnosis and treatment of skin cancer.
Dr. Fischer is an expert in treating basal cell carcinoma, squamous cell carcinoma, malignant melanoma, and other forms of skin cancer. Dr. Fischer specializes in diagnosing and repairing skin lesions, including cosmetic reconstruction following the procedure.
Dr. Fischer received his medical degree from the University of Oklahoma College of Medicine and completed his residency in dermatology at the Boston University-affiliated Roger Williams MedicalCenter in Providence, Rhode Island.
Focusing on his interest in skin cancer, Dr. Fischer completed a highly competitive, rigorous fellowship in Mohs and dermatologic surgery, through the American College of Mohs Surgery, at Boston University-Roger Williams Medical Center.
A scientist at heart, Dr. Fischer received his bachelor’s and master’s degrees in mechanical and aerospace engineering, graduating summa cum laude from Oklahoma State University and conducting research for NASA. He is a member of the American College of Mohs Surgery and the American Society for Dermatologic Surgery,.